Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, sale, and high-value medical consumables in China. The company provides products for orthopedics, minimally invasive surgery, neurosurgery, wound surgery, and dentistry, etc. It also exports its products to various countries and regions. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Compa… Read more
Market Cap & Net Worth: Double Medical Technology Inc (002901)
Double Medical Technology Inc (SHE:002901) has a market capitalization of $2.53 Billion (CN¥18.59 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #11333 globally and #2641 in its home market, demonstrating a 1.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Double Medical Technology Inc's stock price CN¥44.89 by its total outstanding shares 414019506 (414.02 Million).
Double Medical Technology Inc Market Cap History: 2017 to 2026
Double Medical Technology Inc's market capitalization history from 2017 to 2026. Data shows growth from $1.98 Billion to $2.53 Billion (13.29% CAGR).
Double Medical Technology Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Double Medical Technology Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.81x
Double Medical Technology Inc's market cap is 0.81 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
4.88x
Double Medical Technology Inc's market cap is 4.88 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.98 Billion | $594.01 Million | $295.56 Million | 3.33x | 6.69x |
| 2018 | $1.58 Billion | $772.47 Million | $371.45 Million | 2.04x | 4.25x |
| 2019 | $3.20 Billion | $1.26 Billion | $465.49 Million | 2.55x | 6.88x |
| 2020 | $4.02 Billion | $1.59 Billion | $605.68 Million | 2.53x | 6.63x |
| 2021 | $2.79 Billion | $1.99 Billion | $673.31 Million | 1.40x | 4.14x |
| 2022 | $1.90 Billion | $1.43 Billion | $92.56 Million | 1.33x | 20.55x |
| 2023 | $2.27 Billion | $1.53 Billion | $58.96 Million | 1.48x | 38.48x |
| 2024 | $1.74 Billion | $2.14 Billion | $356.80 Million | 0.81x | 4.88x |
Competitor Companies of 002901 by Market Capitalization
Companies near Double Medical Technology Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Double Medical Technology Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Double Medical Technology Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, Double Medical Technology Inc's market cap moved from $1.98 Billion to $ 2.53 Billion, with a yearly change of 13.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.53 Billion | -5.24% |
| 2025 | CN¥2.67 Billion | +53.60% |
| 2024 | CN¥1.74 Billion | -23.30% |
| 2023 | CN¥2.27 Billion | +19.28% |
| 2022 | CN¥1.90 Billion | -31.77% |
| 2021 | CN¥2.79 Billion | -30.58% |
| 2020 | CN¥4.02 Billion | +25.45% |
| 2019 | CN¥3.20 Billion | +102.99% |
| 2018 | CN¥1.58 Billion | -20.26% |
| 2017 | CN¥1.98 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Double Medical Technology Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.53 Billion USD |
| MoneyControl | $2.53 Billion USD |
| MarketWatch | $2.53 Billion USD |
| marketcap.company | $2.53 Billion USD |
| Reuters | $2.53 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.